Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Asha Surendranathan"'
Autor:
Jennifer H. Black, Asha Surendranathan, Kristen Ganjoo, Larry D. Cripe, Arthur E. Frankel, Angela White
Publikováno v:
Cancer. 106(10)
BACKGROUND The safety and efficacy of the interleukin-2 diphtheria toxin fusion protein (DAB389IL2; denileukin diftitox) directed against the IL-2 receptor (IL-2R) was tested in patients with recurrent or refractory chronic lymphocytic leukemia (CLL)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d39c03a496feac6961c4fc0db12fcf
https://pubmed.ncbi.nlm.nih.gov/16586495
https://pubmed.ncbi.nlm.nih.gov/16586495
Autor:
Robert O. Kerr, Jesus G. Berdeja, Philip Kuriakose, Jennifer H Black, Asha Surendranathan, Francesco Turturro, Arthur E. Frankel
Publikováno v:
Blood. 104:4824-4824
Therapeutic options for chronic lymphocytic leukemia (CLL) at relapse are limited because of myelosuppressive toxicity. Denileukin diftitox (ONTAK®, Ligand Pharmaceuticals) is a genetically engineered fusion protein comprising the enzymatically acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbbb83040554ad4f93fc9c6e8eb7f5ff
https://doi.org/10.1182/blood.v104.11.4824.4824
https://doi.org/10.1182/blood.v104.11.4824.4824
Autor:
Arthur E. Frankel, Asha Surendranathan, Jennifer H. Black, Angela White, Kristen Ganjoo, Larry D. Cripe
Publikováno v:
Cancer (0008543X); May2006, Vol. 106 Issue 10, p2158-2164, 7p